HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China flag China · Delayed Price · Currency is CNY
7.20
-0.01 (-0.14%)
Apr 25, 2025, 2:45 PM CST

HPGC Renmintongtai Pharmaceutical Company Description

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China.

The company offers Chinese and Western patent medicines, Chinese herbal medicines, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosmetics products.

It also provides logistics services, including warehousing and distribution services; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, and hemodialysis and kidney disease treatment.

Further, it is involved in medical and commercial distribution, and third-terminal sales; and operation of Chinese medicine and outpatient clinics.

It serves its products through e-commerce platform, a chain of direct stores and online B2C, O2O, WeChat mall mini programs, etc. The company was founded in 1950 and is headquartered in Harbin, China.

HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.

HPGC Renmintongtai Pharmaceutical Corporation
Country China
Founded 1950
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,870
CEO Weidong Zhu

Contact Details

Address:
No. 418 Haiyao Road
Harbin, 150076
China
Phone 86 45 1846 00888
Website hyrmtt.com.cn

Stock Details

Ticker Symbol 600829
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE000000G05
SIC Code 5122

Key Executives

Name Position
Ping Guan Deputy GM and Chief Financial Officer